“I think what we have is a universal vaccine against diverse respiratory threats,” Pulendran said.

  • Bob Robertson IX
    link
    fedilink
    English
    arrow-up
    4
    ·
    25 days ago

    The only thing the FDA needs to hear is that this will make a lot of money for the shareholders.